Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
about
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel diseaseThe effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responsesUnraveling the Effect of Immunogenicity on the PK/PD, Efficacy, and Safety of Therapeutic ProteinsExploring new territory: considering the futureTNF superfamily: a growing saga of kidney injury modulators.What is the utility of routine ANA testing in predicting development of biological DMARD-induced lupus and vasculitis in patients with rheumatoid arthritis? Data from a single-centre cohort.Optic neuritis associated with adalimumab in the treatment of uveitis.Possible association of etanercept, venous thrombosis, and induction of antiphospholipid syndrome.Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.Efficacy and safety of adalimumab in Crohn's diseaseDrug-induced lupus: an update on its dermatologic aspects.Mechanisms of tumor necrosis factor α antagonist-induced lupus in a murine model.Adalimumab-induced lupus serositis.The role of cytokine in the lupus nephritis.Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α.Drug-induced glomerular disease: immune-mediated injury.Correlation of antinuclear antibody and anti-double-stranded DNA antibody with clinical response to infliximab in patients with rheumatoid arthritis: a retrospective clinical study.The safety of etanercept for the treatment of plaque psoriasis.Autoimmunogenicity during anti-TNF therapy in patients with psoriasis and psoriatic arthritis[Systemic lupus erythematosus induced by isoniazid: a rare complication to fear].The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus NephritisThe effect of TNFalpha blockade on the antinuclear antibody profile in patients with chronic arthritis: biological and clinical implications.Anti-Tumor Necrosis Factor-α Induced Systemic Lupus Erythematosus().TNFα inhibitor induced lupus-like syndrome (TAILS) in a patient with IBD.Vasculitis associated with tumor necrosis factor-α inhibitorsThe Changing Landscape of Renal InflammationTNFalpha blockade in human diseases: an overview of efficacy and safety.Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsThe role of tumor necrosis factor-alpha in systemic lupus erythematosusLessons for lupus from tumour necrosis factor blockade.Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.Autoantibody production in anti-TNF-alpha-treated patients.Infliximab in dermatological treatment: beyond psoriasis.Tumour necrosis factor inhibitors in ankylosing spondylitis.Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximab.Biological therapies for the treatment of juvenile idiopathic arthritis: Lessons from the adult and pediatric experiences.Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus.Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo ClinicCardiac Tamponade as a Presenting Manifestation of Infliximab-Induced Lupus in Patient Treated for Crohn's Disease.Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA.
P2860
Q26822029-876EE246-08F8-496A-80CC-5BD1DB170E0AQ27022645-0050A1F7-E214-4B3A-A8DC-5F10E9021A2CQ28066498-E663DDDE-66B7-48CC-A6B8-487A2C623D7DQ28222277-A38FAB27-E19E-48FE-8412-EC98F8526D59Q30479123-008EADEE-66C4-42DF-AE0D-F2156B56C8A0Q30826279-1F2C745A-5BA7-41A9-AFED-5C7E786947EAQ33681462-8399E59F-F7E5-4608-B275-C6351F0F52B8Q33737258-A9F55EA3-678B-4905-837D-5ACCD03CD05DQ34023923-759774AD-89FB-4999-8C82-AB70615E8AF0Q34408865-54883728-5552-4078-A66E-1F24D0682B6BQ34611958-02DD422A-BCFF-483B-8ED4-E6AAAED27BCDQ34790990-D98B2C86-216E-482B-A24F-FFC929BB2669Q35203953-92102F04-A908-4DB7-800D-E115E7D23682Q35418333-D2134A12-64D0-4F20-BD14-515E548BF525Q35808834-44BFACDA-E615-4BDE-835B-5E8C1E64B5F9Q35816996-5F6D2897-43D4-4E82-8F58-A29E8E36ED6CQ35907845-0A60A67D-4E7F-452C-B458-A2D1721B7460Q35919214-91CA779F-43D8-42A4-826A-F7969041BB0CQ36048476-BBB85443-CE5E-42A0-9A79-50B955685404Q36080421-86CCD6E4-25E7-436E-8A17-4FA54A3009D8Q36299959-10426633-405B-4AE5-8A0B-2D9E599E8CD7Q36373315-EE602723-7781-4E7C-B0E1-B2F7490097ABQ36418745-421BAB5F-61AD-466A-8C8C-F20ED162D695Q36453770-8E533A97-43BE-414E-8B6F-3B82B7BF96E5Q36513081-5C0A3439-BA60-45E5-B382-319CBE1AC91EQ36535196-25E3B724-54BC-47B2-8D21-9CE1741FD111Q36536861-690E10E9-138D-4F9B-97D7-9C92CC93C560Q36579988-FD068AD7-78C5-4D86-931B-E1A04D191400Q36641608-CACA6427-32BE-44B0-B075-DA4F3C04E168Q36677012-8DF028CC-9F5D-491E-832D-0F1BAAD727E5Q36847326-BCD72284-487F-4B65-99B1-153CC371676FQ36958337-0DED1943-3EAB-4C11-865E-19D53AD0D797Q37032659-FAFDFB3E-64E1-446D-8495-57967582A052Q37142118-653A4C35-FF0E-4DC8-B27B-002F2C8E5977Q37270902-854F3C6B-3BD5-4A04-8B49-7A873DBB8899Q37290665-5E601C72-684D-4838-9161-CC4E5599B61BQ37353822-BD28B284-DAB6-4852-AAA5-2A5446631FAFQ37406698-E410FCA3-7C71-4FBA-A458-471801EDEEFAQ37593973-C1D4B843-173C-4218-8F14-6221F343E4D3Q37599165-FCD56103-58E6-44B0-98E5-BDC50E39E2BF
P2860
Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Systemic lupus erythematosus i ...... rapy: a French national survey
@ast
Systemic lupus erythematosus i ...... rapy: a French national survey
@en
Systemic lupus erythematosus i ...... rapy: a French national survey
@nl
type
label
Systemic lupus erythematosus i ...... rapy: a French national survey
@ast
Systemic lupus erythematosus i ...... rapy: a French national survey
@en
Systemic lupus erythematosus i ...... rapy: a French national survey
@nl
prefLabel
Systemic lupus erythematosus i ...... rapy: a French national survey
@ast
Systemic lupus erythematosus i ...... rapy: a French national survey
@en
Systemic lupus erythematosus i ...... rapy: a French national survey
@nl
P2093
P2860
P3181
P356
P1476
Systemic lupus erythematosus i ...... rapy: a French national survey
@en
P2093
Christian Marcelli
Eric Boucquillard
Jean Louis Siame
Jean Sibilia
Michel De Bandt
Sebastian Prouzeau
Xavier Mariette
P2860
P2888
P304
P3181
P356
10.1186/AR1715
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1012596633